Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Board Change

22 May 2018 07:00

RNS Number : 7955O
Pets At Home Group Plc
22 May 2018
 

FOR IMMEDIATE RELEASE, 22 MAY 2018

 

 

Pets at Home Group Plc: Board Change

 

Professor Susan Dawson appointed Independent Non-Executive Director

 

Pets at Home Group Plc, the UK's leading pet care business, announces that Tessa Green, Independent Non-Executive Director, has decided to step down from the Board at the Company's Annual General Meeting (AGM) which will be held on 12 July 2018. Tessa has been a Director of Pets at Home since 2014. Tessa will be succeeded at the AGM by Professor Susan Dawson. Susan is a veterinary academic and has been Professor and Dean of the Institute of Veterinary Science at the University of Liverpool for the last seven years.

 

Susan started her career in veterinary practice in 1983 and has held management positions at Liverpool University for the last ten years. Susan has strong Board experience relating to the veterinary world, including as Senior Vice President of the British Small Animal Veterinary Association, a Council Member for the Royal College of Veterinary Surgeons, and a Founder Member of the Veterinary Schools Council.

 

Tony DeNunzio, Chairman of Pets at Home, said: "I would like to thank Tessa for her excellent contribution over the last four years and wish her every success in the future. We are delighted to welcome Susan to the Board; she brings very strong veterinary experience to the role and is an expert on the training and wellbeing of vets, which will be hugely valuable as we continue to develop this area of the business."

 

ENDS

 

On appointment, Susan will become Chair of the Corporate and Social Responsibility (CSR) Committee and the Pets Before Profit Committee. She will also be a member of the Remuneration Committee and the Nominations and Governance Committee.

 

There is no further information to be disclosed under paragraph 9.6.13 of the UK Listing Authority Listing Rules. This announcement contains inside information.

 

Investor Relations Enquiries

 

Pets at Home Group Plc: +44 (0)161 486 6688

Amie Gramlick, Director of Investor Relations

 

Media Enquiries

 

Pets at Home Group Plc: +44 (0)161 486 6688

Brian Hudspith, Director of Corporate Affairs

 

Maitland: +44 (0)20 7379 5151

James McFarlane

Joanna Davidson

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 448 superstores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 461 First Opinion practices located both in our stores and in standalone locations, as well as four Specialty Referral centres. For more information visit: http://investors.petsathome.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUCAAUPRGBG
Date   Source Headline
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSAppointment of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.